Skip to main content

Table 5 Outcomes for patients receiving feedback plus the goal-setting and action-planning worksheet versus feedback alone

From: Feedback GAP: pragmatic, cluster-randomized trial of goal setting and action plans to increase the effectiveness of audit and feedback interventions in primary care

  Feedback + worksheet Feedback alone Model-based differences in quality of care outcomes
  N = 1,832 N = 2,223       
Continuous outcomes    MD 95% CI Missing Adjusted MD 95% CI Missing
Systolic BP 128 ±18 128 ±16 0.35 -2.24, 2.95 554 -0.05 -2.11, 2.02 743
Diastolic BP 72 ±11 73 ±11 -1.48 -3.34, 0.38 554 -0.72 -2.18, 0.75 743
LDL 2.1 ±0.8 2.0 ±0.8 0.04 -0.06, 0.14 643 0.04 -0.02, 0.10 927
HbA1c%^ 7.2 ±1.3 7.4 ±1.5 -0.24 -0.38, -0.09 572 -0.20 -0.33, -0.06 794
Composite score 72 ±26 70 ±28 4.85 -0.52, 10.21 0 1.76 -1.37, 4.89 0
Dichotomous outcomes    RR 95% CI   Adjusted RR 95% CI  
LDL at target 866 (47%) 1,119 (50%) 0.97 0.85, 1.13   0.97 0.90, 1.06  
BP at target 965 (53%) 1,023 (46%) 1.21 1.05, 1.40   1.15 1.02, 1.29  
BP test in 6 M 1,491 (81%) 1,541 (69%) 1.25 1.11, 1.42   1.16 1.06, 1.26  
A1C test in 6 M^ 947 (71%) 1,067 (65%) 1.12 0.98, 1.28   1.07 0.95, 1.21  
FBG test in 24 M 1,596 (87%) 1,918 (86%) 1.03 0.97, 1.10   1.03 0.98, 1.08  
LDL test in 12 M 1,217 (66%) 1,480 (67%) 1.03 0.93, 1.16   1.02 0.93, 1.12  
ACR test in 12 M^ 851 (64%) 1,060 (65%) 1.02 0.87, 1.20   1.05 0.93, 1.20  
Rx ASA* 552 (75%) 615 (73%) 1.03 0.95, 1.11   0.99 0.96, 1.03  
Rx statin 1,309 (72%) 1,686 (76%) 0.96 0.89, 1.03   0.97 0.94, 1.00  
Rx ACE/ARB^ 647 (83%) 679 (84%) 1.05 0.97, 1.14   0.98 0.95, 1.00  
Rx beta blocker* 440 (59%) 514 (61%) 1.00 0.90, 1.10   0.99 0.95, 1.03  
Rx insulin^ 351 (26%) 426 (26%) 0.99 0.85, 1.16   1.01 0.99, 1.04  
  1. All models adjusted for clustering. Adjusted models also controlled for baseline values of dependent variable.
  2. Legend: ^Analysis restricted to patients with diabetes, *Analysis restricted to patients with IHD, ~ Target BP 130/80 for diabetes and 140/90 for IHD and Target LDL<2.
  3. MD mean difference, RR relative risk, IHD ischemic heart disease, BP blood pressure, A1C haemoglobin A1c, FBG fasting blood glucose, LDL low density lipoprotein cholesterol, ACR albumin-to-creatinine ratio, ASA aspirin, ACE/ARB angiotensin-modifying agent, Rx active prescription, CI confidence interval, M months.